CClinicalTrials.gg
Active, not recruitingNCT07577193Updated May 11, 2026

Effectiveness of Xenogenic Collagen Matrix in Modification of Mucosal Phenotype Around Dental Implants

An interventional study of All dental implants will be placed in edentulous the area with application of free gingival graft (Group I) or with incorporation of porcine collagen matrix (Group II). in Soft Tissue Atrophy, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 25 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Oct 2025, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
25 Years to 50 Years
Sex
All
01

Study summary

Aim of the study The rationale for conducting the present study is to evaluate the efficacy of porcine collagen matrix in the management of defective width of keratinized mucosa around dental implant.

Read the detailed description

Therefore, the primary objective is to evaluate the integration of porcine collagen matrix with the recipient site and measuring the amount gained of keratinized mucosa. The secondary objective is to assess the pink esthetic score around dental implant following porcine collagen matrix compared to the free gingiva graft.

02

Conditions studied

  • Soft Tissue Atrophy
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patient between 25-50 years old.
  2. Remaining bone height of more than 8 mm, remaining bone width of 6 mm
  3. Inadequate keratinized soft tissue \<2 mm (13).
  4. Favorable pattern of occlusion.
  5. Good oral hygiene.
  6. Patient ability to comply with the required recall visits.

Exclusion criteria

Exclusion Criteria:

  1. Insufficient bone width (less than 6 mm) mesiodistal or buccolingually.
  2. Patients having any uncontrolled systemic disease which could affect bone healing.
  3. Patients treated with radiotherapy to the head and neck area within the past 12 months.
  4. Heavy Smokers (more than 20 cigarette per day) according to WHO.
  5. Inability or unwillingness to return for follow-up visits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    dental implant with application of free gingival graft

    Group I: will include 10 patients in which participants will receive dental implant with application of free gingival graft which will be taken from the hard palate to increase the width of keratinize gingiva

    Procedure: All dental implants will be placed in edentulous the area with application of free gingival graft (Group I) or with incorporation of porcine collagen matrix (Group II).

  • Experimental
    dental implants with application of porcine collagen matrix

    Group II: will include 10 patients in which participants will receive dental implants with application of porcine collagen matrix to increase the width of keratinize gingiva.

    Procedure: All dental implants will be placed in edentulous the area with application of free gingival graft (Group I) or with incorporation of porcine collagen matrix (Group II).

Interventions

  • ProcedureAll dental implants will be placed in edentulous the area with application of free gingival graft (Group I) or with incorporation of porcine collagen matrix (Group II).

    Group I: All patients will be operated under local anaesthesia;. .. Two vertical releasing incisions delineated the partial thickness flap. The flap will be apically positioned and sutured. A gingival graft will be taken from the hard palate. The graft will be 1 to 2 mm in thickness and its size will be determined depending on recipient size and free from adipose tissue. The graft will be trimmed to adapt to the shape and size of the recipient site then suturing the graft to the recipient sites by using 4-0 vicryl suture. Group II: All patients will be operated under the same local anaesthetic as in group I. Crestal incision will be performed and full thickness mucoperiosteal flap will be reflected just to access the site. Two vertical releasing incisions delineated the partial thickness flap. The flap will be apically positioned and sutured. Porcine collagen matrix will be placed in the recipient site and sutured by using 4-0 vicryl suture.

06

What researchers measure

Primary outcomes

  1. Clinical Evaluation:

    Wound Healing Status: Presence or absence of soft tissue dehiscence or wound infection. Unit: Yes/No. Time Frame: Post-operative follow-up visits.

    Time frame: 3 months

  2. clinical

    Implant Stability: Implant stability measured using Resonance Frequency Analysis (Osstell). Unit: Implant Stability Quotient (ISQ). Time Frame: Immediately post-placement and at 3 months.

    Time frame: 3 months

  3. Clinical

    Surgical Operation Time: Duration of implant site preparation and graft fixation. Unit: Minutes. Time Frame: During surgery.

    Time frame: 3 months

  4. clinical

    Post-operative Pain Intensity: Patient-reported pain measured using Visual Analogue Scale (VAS). Unit: VAS score (0-10). Time Frame: Day 1, Day 3, and 1 week post-operatively.

    Time frame: 3 months

Secondary outcomes

  1. Clinical periodontal parameters

    Plaque Index (PI): Dental plaque accumulation around implants measured using the Plaque Index. Unit: PI score. Time Frame: 3 months post-operatively.

    Time frame: 3 months

  2. radiographic

    1. Implant Position Accuracy Description: Evaluation of the accuracy of dental implant placement in relation to adjacent teeth and surrounding vital anatomical structures using Cone Beam Computed Tomography (CBCT). Unit of Measure: Deviation distance in millimeters (mm) Time Frame: At 6 months post-implant placement 2. Crestal Bone Level Changes - Mesiodistal Description: Measurement of crestal bone level changes in the mesiodistal direction around the dental implant using CBCT. Unit of Measure: Millimeters (mm) Time Frame: At 6 months post-implant placement 3. Crestal Bone Level Changes - Buccolingual Description: Measurement of crestal bone level changes in the buccolingual direction around the dental implant using CBCT. Unit of Measure: Millimeters (mm) Time Frame: At 6 months post-implant placement

    Time frame: 6 months

  3. clinical parameters

    Probing Depth (PD): Peri-implant probing depth to assess peri-implant tissue health. Unit: mm. Time Frame: 3 months post-operatively.

    Time frame: 3 months

  4. clinical perodontal parameters

    Clinical Attachment Level (CAL): Measurement from cemento-enamel junction to base of peri-implant sulcus/pocket. Unit: mm. Time Frame: 3 months post-operatively.

    Time frame: 3 months

  5. clinical periodontal parameters

    Keratinized Tissue Width (KTW): Width of keratinized mucosa around implant site. Unit: mm. Time Frame: 3 months post-operatively.

    Time frame: 3 months

  6. clinical periodontal parameters

    Gingival Thickness (GT): Thickness of peri-implant gingiva. Unit: mm. Time Frame: 3 months post-operatively.

    Time frame: 3 months

07

Study locations

1 site
  • faculty of dentistry Mansoura university, Mansoura, 35516
    Al Mansurah, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07577193
Lead sponsor
Mansoura University
Responsible party
Sponsor
First posted
May 11, 2026
Start date
Oct 1, 2025
Primary completion
Sep 28, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
May 11, 2026

Study contacts

mohamad sa haichal, bachelor
principal investigator · faculty of dentistry Mansoura university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion